Drug intelligence / Profile preview

selaginella doederleinii

Development stage
Preclinical
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
Administration
Oral (decoction Or Granule), Topical (traditional Use)
01

Overview

Selaginella doederleinii is a perennial herbaceous plant in the family Selaginellaceae, widely distributed in Southeast Asia and southern China. Known as 石上柏 (Shi Shang Bai) in Chinese medicine, it has been traditionally used for its broad pharmacological activities including anticancer, antiviral, anti-inflammatory, antioxidant, antihyperuricemia (gout), antibacterial, antihypertensive effects and potential benefits for Alzheimer's disease. The plant contains diverse bioactive compounds such as biflavonoids (amentoflavone and robustaflavone derivatives), lignans ((-)-lirioresinol A/B), phenolic acids (ferulic acid), anthraquinones (emodin), coumarins and polysaccharides. Its mechanism of action is multifaceted—biflavonoids are believed to contribute to its antitumor activity via cytotoxicity against cancer cells; other constituents provide anti-inflammatory or antioxidant effects. In traditional Chinese medicine it is used to clear heat and resolve fire toxicity; clear damp-heat; invigorate blood circulation; disperse stagnant blood; remove tumors and disperses accumulations[3][4][10]. Modern research supports its use especially for various cancers but also suggests potential applications in neurodegenerative diseases.

Other names
石上柏Shi Shang BaiSelaginella HerbSelaginella doederleinii Hieron
02

Targets

CYP1A2 (Cytochrome P450 1A2)CYP2C8 (Cytochrome P450 2C8)CYP3A7 (Cytochrome P450 3A7)LDH (L-lactate dehydrogenase A chain)MYC (MYC proto-oncogene protein)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on selaginella doederleinii.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on selaginella doederleinii.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call